drugset / Trial / NCT02182856
Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD
RandomizedCrossoverDouble-blindTreatment
Summary
Study to compare the effects of nebulised salbutamol or ipratropium alone in patients with COPD with those of combined salbutamol and ipratropium nebuliser solution on arterial oxygen saturation (SaO2) and to characterise patients with COPD (chronic obstructive pulmonary disease) at risk of significant arterial oxygen desaturation following nebulised salbutamol.
Timeline
- Start
- 1998-02
- Primary completion
- 2000-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ipratropium | Small molecule | 500 ug | Inhaled |
| Subject | Salbutamol | Unknown | 3 mg | Inhaled |
| Subject | Salbutamol | Unknown | 6 mg | Inhaled |